Research Wilmot Clinical Trials Office Steps Up Its Game By Leslie Orr Nov. 2, 2021 Many small business growth stories — whether it involves a food retailer, a fashion brand, or even Zoom, which was much less known until 2019 — have things in common with the Wilmot Cancer ...
Research URMC Part of Collaboration Awarded $10M for Pediatric Concussion Research By Susanne Pallo Oct. 11, 2021 URMC researchers will enroll 240 children and teens (11-18 years old) from the Rochester area in a collaborative national study to predict which kids will develop prolonged symptoms after concussion.
Patient Care New Dialogue Issue Spotlights the People, Teams, Behind the Scenes that Help Wilmot Succeed By Leslie Orr Sep. 14, 2021 Read the 2021 edition of Dialogue, a magazine for community supporters of the Wilmot Cancer Institute. Filled with inspiring stories about patients and the talented people who work at Wilmot.
Research Building on Prior Research, Wilmot Makes Progress on Vexing Liver Cancer By Leslie Orr Sep. 13, 2021 New data provide a roadmap for targeting rare liver tumors with immunotherapy.
Research What we know about aducanumab – the new FDA approved drug to treat Alzheimer’s disease By Kelsie Smith Hayduk Jun. 9, 2021 Earlier this week, the federal Food and Drug Administration (FDA) approved the use of the drug aducanumab to treat Alzheimer’s disease – making it the first new drug in nearly 20-years to treat the ...
Research Do COVID Vaccines (and Boosters) Protect You During Pregnancy? By Susanne Pallo May. 17, 2021 By all accounts, COVID vaccines in use in the U.S. today are highly effective, but pregnant people have largely been left out of the research behind the vaccines. A new study at URMC will follow 135 ...
Research Can’t Quit Smoking? Maybe You Haven’t Gotten the Right Message By Leslie Orr Apr. 5, 2021 What kinds of text messages work best to help smokers quit? Wilmot is using an innovative approach and reaching out to diverse communities.
Research New Coronavirus Vaccine Study Seeks to “Boost” Immune Response By Mark Michaud Feb. 25, 2021 URMC and RRH have begun a new clinical trial that will evaluate the safety and efficacy of a third dose of the Pfizer/BioNTech COVID-19 vaccine. This study represents an important step in the ...
Research Study of School Children with Asthma Provides Evidence for ‘Research Participation Effect’ By Scott Hesel Sep. 21, 2020 A study of school-children with asthma showed evidence that simple follow-up calls to see how these children were doing increased the number of symptom-free days that they experienced.
Research Phase 3 AstraZeneca Coronavirus Vaccine Study Reopens at URMC By Mark Michaud Sep. 1, 2020 The University of Rochester Medical Center is joining a phase 3 clinical trial for a potential coronavirus vaccine being developed by AstraZeneca and the University of Oxford known as AZD1222.
